Sugary drink tax models show health gains, cost reductions, but vary by tax design

June 22, 2020

DALLAS, June 22, 2020 -- A simulation model of different designs of taxes on sugary drinks, which are linked to obesity, cardiovascular disease and diabetes, suggests that all tax designs would generate substantial health gains as well as lower health costs in the U.S., according to new research published today in the American Heart Association's flagship journal Circulation. However, some of the models perform better than others.

Frequent consumption of sugary drinks is strongly linked to weight gain, Type 2 diabetes and cardiovascular disease. Sugary drinks remain the largest source of added sugars intake in the U.S., with about 60% of children and half of adults consuming sugary drinks every day.

Boston researchers created a nationally representative microsimulation model to test three types of taxation on sugary drinks: a flat "volume tax" by drink volume ($0.01 per ounce), the only type used in U.S. cities to-date; a "tiered sugar content tax" by 3 levels of sugar content (ranging from $0.00 for less than 5 grams of added sugars per 8 ounces, to $0.02 per ounce of added sugars for more than 20 grams of added sugars per 8 ounces); and a "fixed sugar content tax" by absolute sugar content ($0.01 per teaspoon of added sugars, regardless of the number of ounces).

Under the simulation scenario, the researchers found all three tax structures would generate tax revenue, lower health care costs and prevent cardiovascular disease events and diabetes cases. However, the tiered tax and sugar content tax could generate the largest health gains and cost savings. Any of the tax designs could be effective public health policy tools that may be able to reduce consumption of sugary drinks, and thus improve health and overall well-being, the researchers noted.

Younger adults (ages 35 to 44 years), blacks and Hispanics, and adults with lower incomes were estimated to experience the largest health gains. Thus, the research suggested that all three sugary drink tax designs may reduce health disparities, particularly among these subgroups.

"Overwhelming evidence confirms that food prices have a big impact on purchasing decisions. Taxing sugary drinks influences consumer choices, reducing consumption," said Yujin Lee, Ph.D., a postdoctoral fellow of the Friedman School of Nutrition Science and Policy at Tufts University in Boston and the co-lead study author. "U.S. cities have introduced volume taxes on sugary drinks. But our findings suggest that a tiered fixed sugar content tax would be best, reducing consumer intakes while also encouraging manufacturer reformulations to reduce the sugar content of their products."

Researchers estimated the potential health impact, quality-adjusted life-years (a measure of disease burden) costs and cost-effectiveness of volume-based and sugar content-based (tiered, fixed) sugary drinks taxes in the U.S. They used nationally representative data and a validated computer simulation model that incorporated data on adults ages 35 to 80 across three National Health and Nutrition Examination Survey cycles (2009 to 2014) to derive sociodemographics, cardiometabolic risk factors and lifestyle habits. Net costs were calculated from adding the expense of the government's implementation of tax collection plus the industry's compliance and reformulation costs, then subtracting health care savings from fewer medical screenings, treatments, medications, surgeries and supplies, discounted at 3% annually.

In the U.S., seven cities (Philadelphia; Seattle; Boulder, Colorado; and Berkeley, Albany, Oakland and San Francisco, California) currently have volume-based taxes for sugary drinks as does Mexico, Belgium, Brunei, Norway and the Philippines. The American Heart Association currently advocates for a tiered sugar content tax as an effective approach to achieve better health and expand healthier options. The Association has also supported volume-based sugar taxes, which were able to be passed in those seven cities. Taxing sugary drinks based on sugar content (i.e., tiered or fixed tax) has been implemented in other countries, including Chile, Ireland, the United Kingdom, France, Portugal and South Africa.

The simulation found that, compared to the status quo, over a lifetime, a volume-based tax could:However, the tiered- and absolute-sugar content tax structures could double those gains.

In the simulation model, a tiered tax would:Similarly, the simulation estimated that an absolute content tax would:For this study, the researchers defined sugary drinks as soft drinks/sodas, juice drinks, sports drinks, pre-sweetened iced tea or coffee, and electrolyte replacement drinks with 5 or more grams of added sugars per 12 ounces. Consumption of sugary drinks, including their added sugars content for each person, was derived from two, 24-hour dietary recalls per person.

Given that the projections and modeling are based on observational data, the study does not establish a causal link between the health and cost effects of these sugary drink tax designs in U.S. adults. Rather, the estimates provide evidence that can be considered and incorporated into the design, implementation and evaluation plans of potential taxes, including at local, state or federal levels. The model's population also did not include children, adolescents or adults under age 35.

"Our study underscores the importance of considering different sugary drink tax designs in any new local, state and federal efforts to improve health outcomes and save health care costs," Lee said.
The co-lead author is Dariush Mozaffarian, M.D., Dr.P.H. Senior authors are Thomas Gaziano, M.D., M.Sc., and Renata Micha, R.D., Ph.D. Additional co-authors are Stephen Sy, M.S.; Junxiu Liu, Ph.D.; Parke Wilde, Ph.D.; Matti Marklund, Ph.D.; Shafika Abrahams-Gessel, S.M., Dr.P.H. Author disclosures are in the manuscript.

The National Institutes of Health and the American Heart Association funded the study.

Additional Resources:

Available multimedia is on right column of release link -

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public's health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on, Facebook, Twitter or by calling 1-800-AHA-USA1.

American Heart Association

Related Diabetes Articles from Brightsurf:

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to